source
- CSL appoints GSK veteran Deborah Waterhouse as new CEO to steer company through challengesCSL announced that Deborah Waterhouse, former head of GSK's HIV business ViiV Healthcare and former president of GSK Global Health, will become its new chief executive. Waterhouse joins CSL as the…
- FDA accepts new submission for Biohaven’s Vyglxia, opening path to approvalBiohaven announced that the FDA has accepted a refreshed application for its rare disease drug Vyglxia, which targets a nerve‑damaging disorder. Vyglxia is being developed for spinocerebellar atax…